'Fundamental flaws' in the system led to acute shortage of hospital beds, higher occupancy rates and gaps in accessibility of treatment, according to Taub Center

New drug stalls progression of disease for patients who have the BRCA genetic mutations, study by Sheba Medical Center with AstraZeneca and Merck shows